5th International Advanced Research Workshop on In Silico Oncology and Cancer Investigation

22 - 23 October 2012, Athens, Greece.
Cancer is a natural phenomenon and as such it should be amenable to mathematical and computational description. Clinically driven complex multiscale cancer models can produce rather realistic spatio-temporal simulations of concrete clinical interventions such as radio-chemotherapy applied to individual patients.

Clinical data processing procedures and computer technologies play an important role in this context. Following clinical adaptation and validation within the framework of clinico-genomic trials, models are expected to enhance individualized treatment optimization. The latter constitutes the long term goal of the emergent scientific, technological and medical discipline of in silico oncology.

Treatment optimization is to be achieved through experimentation in silico i.e. on the computer. Moreover, provision of insight into tumour dynamics and optimization of clinical trial design and interpretation constitute short- and mid-term goals of this new domain. Researchers working either in the area of in silico oncology or in the broader cancer research domain yet with an interest in computational oncology are invited to submit short papers.

The workshop is meant to be an excellent opportunity for both shaping and advancing the discipline.

Organizing Committee

  • G. Stamatakos, PhD, ICCS - National Technical University of Athens (GR), General Chair
  • Ν. Graf, MD, University Clinic of Saarland (DE)
  • K. Marias, PhD, Foundation for Research and Technology, Hellas (GR)
  • M. Akay, PhD, University of Houston (USA)
  • R.Radhakrishnan, PhD, University of Pennsylvania (USA)
  • D. Dionysiou, PhD, ICCS - National Technical University of Athens (GR)
  • V. Sakkalis, PhD, Foundation for Research and Technology - Hellas (GR)
  • N. Uzunoglu, PhD, ICCS - National Technical University of Athens (GR)

Important Dates
Paper submissions due: September 1, 2012.
Notification of acceptance: September 21, 2012. Camera ready papers due: September 30, 2012.

This year the 5th International Αdvanced Research Workshop on In Silico Oncology and Cancer Investigation will also be the TUMOR project workshop.

The TUMOR project aims at developing a European clinically oriented semantic-layered cancer digital model repository from existing EU projects that will be interoperable with the US grid enabled semantic-layered digital model repository platform at CViT.org (Center for the Development of a Virtual Tumor, Massachusetts General Hospital (MGH), Boston, USA) which is NIH/NCI-caGRID compatible.

For further information, please visit:
http://www.5th-iarwisoci.iccs.ntua.gr

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...